Despite responding to national outrage by promising to lower the price of Daraprim, a drug that fights parasitic infections, pharmaceutical CEO Martin Shkreli has not yet made good on his word. Last month his pharmaceutical company increased the life-saving medication by 5,000%. Now at $900 a pill, a 30-day, 30-pill supply of the drug would cost the average person $27,006 at their local pharmacy. This decision is disastrous for the people relying on the medication. Aimed Alliance will continue to follow the pharmaceutical company and Shkreli’s actions in the coming weeks, but for now, read more here.
Last Updated on May 7, 2020 by Aimed Alliance
